Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.
Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate
Potassium-Retaining Diuretics: Amiloride
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis
Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks.
Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
Laquinimod - New Promising Treatment for Multiple Sclerosis
Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
Neuromyelitis optica spectrum disorder: 2-deoxy-2-[(18)f]fluoro-d-glucose positron emission tomography findings.
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome.
Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease.
Laquinimod for multiple sclerosis.
Arzerra receives approval in Japan

Pages